Myriad Genetics Introduces Online Prenatal Genetic Testing Resource
Provided By GlobeNewswire
Last update: Jan 23, 2025
SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing comprehensive information about reproductive and prenatal genetic testing.
Read more at globenewswire.com
